Achison, Inc. Class A News
Alexion Pharmaceuticals to Acquire Achillion in $930 Million Deal
Alexion is seeking to expand its pipeline of rare disease treatments through the acquisition.
Achillion Pharma Stock Soars as New Drug Gets FDA Breakthrough Status
Formerly an orphan-drug designee, Danicopan treats PNH, a rare acquired blood disease.
Johnson & Johnson Shuts Insulin Pump Business, Inks Other Deals
Healthcare giant Johnson & Johnson cut costs by laying off 297 staffers tied to its insulin pump business, while also buying a German surgical software company and inking a deal with biotech company targeting hepatitis B treatments.
S&P Reaches New Record as Stocks Rally Amid Subsiding Irma, North Korea Fears
Wall Street starts the week with a rally.
Dow, S&P 500 on Track for Best Day in 6 Months as Irma Worries Ease
The Dow is up more than 250 points.
Gap Stock Slumps On Wider Q1 Loss, Grim Profit Outlook As Shoppers Shun Casual Apparel
"Supply chain challenges and persistent delays significantly limited the brand's responsive abilities" to changing consumer trends, CEO Sonia Syngal told investors Thursday.
Big Lots Stock Crumbles After Surprise Q1 Loss As Inflation, Gas Price Surge Bites Spending
"We believe the slowdown was caused by the spending pressure our consumers felt from higher gas prices and broader inflation," said CEO Bruce Thorn.
Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion
Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.